Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Indore SEZ project: Lupin seeks more time from Government to complete project

      Indore SEZ project: Lupin seeks more time from Government to complete project

      Farhat Nasim19 April 2019 9:45 AM IST
      Lupin has requested "for extension of letter of permission (LoP) beyond April 11, 2019, for one year up to April 11, 2020," according to the agenda of...
      Granules India gets USFDA nod for Acetaminophen extended release tablets

      Granules India gets USFDA nod for Acetaminophen extended release tablets

      Farhat Nasim18 April 2019 11:43 AM IST
      The recently approved product, Acetaminophen 650 mg extended-release tablets are used primarily for temporary pain management. Granules also...
      Roche launches Emicizumab in India under brand name Hemlibra to treat Hemophilia A

      Roche launches Emicizumab in India under brand name Hemlibra to treat Hemophilia A

      Farhat Nasim18 April 2019 11:30 AM IST
      Hemlibra is the first weekly subcutaneous prophylaxis injection shown to prevent or reduce the frequency of bleeding episodes and improve the quality...
      Zydus Cadila gets final USFDA nod to generic version of Diamox for injection

      Zydus Cadila gets final USFDA nod to generic version of Diamox for injection

      Farhat Nasim18 April 2019 10:00 AM IST
      Acetazolamide injection is a generic version of Diamox for injection.New Delhi: Drug firm Zydus Cadila Wednesday said it has received the final nod...
      USFDA bans sale of Transvaginal Surgical Mesh citing safety concerns

      USFDA bans sale of Transvaginal Surgical Mesh citing safety concerns

      Farhat Nasim17 April 2019 9:50 AM IST
      Transvaginal Surgical Mesh, made of synthetic or biological material, are commonly implanted in women to repair weakened or damaged tissue and provide...
      Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia

      Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia

      Farhat Nasim17 April 2019 9:45 AM IST
      Zydus Cadila Group Chairman Pankaj R Patel said this innovation has the potential to bring about a paradigm shift in the management of CKD patients...
      Lupin gets USFDA nod to generic version of Prozac tablets

      Lupin gets USFDA nod to generic version of Prozac tablets

      Farhat Nasim16 April 2019 9:45 AM IST
      The company has received approval from the US Food and Drug Administration(USFDA) to market its product which is a generic version of Eli Lilly and...
      Gelesis gets USFDA nod to weight-loss hydrogel pill PLENITY

      Gelesis gets USFDA nod to weight-loss hydrogel pill PLENITY

      Farhat Nasim16 April 2019 9:32 AM IST
      BOSTON: Gelesis, a biotechnology company developing first-in-class hydrogel therapeutics to treat obesity and other chronic diseases related to the...
      Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution

      Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution

      Farhat Nasim15 April 2019 10:05 AM IST
      Bimatoprost Ophthalmic Solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular...
      Dr Reddy

      Dr Reddy's expands injectable portfolio with acquisition of 42 ANDAs in US

      Farhat Nasim15 April 2019 10:00 AM IST
      This transaction will help augment Dr Reddy's Labs injectables product portfolio in the U.S. market and globally.Hyderabad: Dr Reddy's Laboratories...
      Omron Healthcare to introduce COMPLETE, first BP monitor with EKG capability

      Omron Healthcare to introduce COMPLETE, first BP monitor with EKG capability

      Farhat Nasim15 April 2019 9:20 AM IST
      Complete is an upper arm blood pressure (BP) monitor that allows users to simultaneously monitor EKG and blood pressure readings at home. U.S: Omron...
      Suven Life Sciences gets US court nod to buy assets of Rising Pharmaceuticals

      Suven Life Sciences gets US court nod to buy assets of Rising Pharmaceuticals

      Farhat Nasim14 April 2019 10:00 AM IST
      "This court approval brings closure to the sale process for Rising Pharmaceuticals and paves the way for a seamless transition of the portfolio,...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok